Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Recruiting now

Conditions studied: Adenocarcinoma, Carcinoma, Neoplasms

In brief

BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.

Key facts

Study ID

NCT06128343

Run by

University Hospital, Toulouse

People needed

1500

Starts

2023-11-16

Expected to finish

2035-02-28

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
• Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
• Patient with pancreatic adenocarcinoma proven histologically and/or cytologically

You may not qualify if…

• Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
• Pregnant or breastfeeding patient

Where it is running

• Rangueil hospital — Toulouse, France (enrolling)
• Haut-Lévêque Hospital — Bordeaux, France
• Huriez Hospital — Lille, France
• Jean Mermoz private hosptila — Lyon, France
• Béthune hospital center — Béthune, France
• Regional Cancer Center From Montpellier — Montpellier, France
• PAU hospital — Pau, France
• Saint Eloi Hospital — Montpellier, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.